HEMATOPOIETIC CELL TRANSPLANT
Clinical trials for HEMATOPOIETIC CELL TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC CELL TRANSPLANT trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC CELL TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple video and kit program help kids take their transplant meds?
Disease control Recruiting nowThis study tests a program called MedMemos for families of children who have had a bone marrow transplant. The program includes four sessions with educational videos and a kit to help manage medications. Researchers want to see if families find it useful and if it helps them take…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: NA • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for older adults with rare blood disorder: safer transplant regimen under study
Disease control Recruiting nowThis study tests a new combination of drugs (busulfan, fludarabine, cyclophosphamide, and r-ATG) as preparation for a stem cell transplant in people aged 40-60 with severe aplastic anemia. The goal is to see if this regimen helps the transplant succeed with fewer failures. The st…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Blood test may let transplant patients stop virus meds earlier
Disease control Recruiting nowThis study looks at whether stem cell transplant patients can safely stop taking a medicine called letermovir earlier if their immune system shows a strong response to CMV. About 105 participants will be monitored to see if this approach reduces infections and side effects compar…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New approach aims to tame immune storms in Half-Matched transplants
Disease control Recruiting nowThis study tests whether giving the immune-suppressing drug tacrolimus earlier than usual can lower the risk of cytokine release syndrome (CRS), a severe inflammatory reaction, in patients receiving a half-matched stem cell transplant for blood cancer. About 20 adults will receiv…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can training transplant doctors in palliative care ease Patients' suffering?
Symptom relief Recruiting nowThis study tests a program called Sentinel that trains stem cell transplant doctors to provide palliative care—like managing symptoms and coping strategies—as part of routine care. The goal is to see if it's feasible and acceptable for patients. Forty adults undergoing stem cell …
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Brain training for transplant survivors: can lumosity fix 'Chemo Brain'?
Symptom relief Recruiting nowThis study tests whether a computer brain-training program (Lumosity) can improve memory and thinking in adults who had a stem cell transplant for blood cancer. About 60 survivors, 3 to 6 months after transplant, will either start training right away or wait 12 weeks. The goal is…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Can online exercise help kids recover after a stem cell transplant?
Symptom relief Recruiting nowThis study tests whether a virtual exercise program can help children and young adults (ages 8-23) recover physical function and quality of life after a stem cell transplant. Participants will have twice-weekly, 30-minute online sessions with a physical therapist for 12 weeks. Th…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 26, 2026 18:53 UTC
-
New study aims to predict dangerous lung infections in young transplant patients
Knowledge-focused Recruiting nowThis study follows 2,000 children who have had or will have a stem cell or organ transplant. Researchers will test for respiratory viruses before and after transplant to see if they can predict who will get a serious lung infection. The goal is to improve screening and care, not …
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC